Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Pomdoctor Limited

Pomdoctor Limited (POM) Stock Overview

Explore Pomdoctor Limited’s financial performance, market position, analyst ratings, and future outlook.

POM●NASDAQ
HealthcareMedical - Pharmaceuticals
$1.85
$0.31(20.13%)
U.S. Market opens in 5h 10m

Pomdoctor Limited (POM)

Meyka AI Score

Z

Key Financials

Market Cap16.4M
P/E Ratio-0.20
EPS (TTM)$-6.84
ROE0.80%
Fundamental Analysis

AI Price Forecasts

1 Month$1.35
3 Months$0.00
1 Year Target$0.00

POM Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Pomdoctor Limited (NASDAQ: POM) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Pomdoctor Limited's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of POM on the NASDAQ shows an RSI of 56.97, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $0.00 for the NASDAQ listing.

Key metrics behind Pomdoctor Limited's NASDAQ-traded stock include a P/E ratio of -0.20 and a market capitalization of 16.4M. Combined with our AI analysis, these give both institutional and retail investors a clear view of POM on the NASDAQ.

Price Performance (NASDAQ: POM)

1-Day Change
24.03%
5-Day Change
23.23%
1-Month Change
-33.45%
3-Month Change
4.37%
6-Month Change
-91.63%
Year-to-Date (YTD) Change
-89.20%
1-Year Change
-99.43%
3-Year Change
-99.21%
5-Year Change
-99.21%
All-Time (Max) Change
-99.21%

Contact Information

https://www.7lk.com
86 20 6231 2277
Yongxu Industrial Park, Guangzhou, GD, 510000

Company Facts

1,650 Employees
IPO DateOct 8, 2025
CountryCN
Actively Trading

Frequently Asked Questions